Search - tctmd.com

Displaying 41 - 57 of 57

Sort: Relevancy | Date

Presentation CIT 2019

Interpretation of Hemodynamic, CT, and Echo Data for TAVR Clinical Decision Making

Presenter: Azeem Latib

March 28, 2019

Presentation ECHO/IMAGING 2019

Echo Hemodynamic Cases

Presenter: Jae K. Oh

March 24, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

Presentation ECHO/IMAGING 2019

Hemodynamics II Echo Quantification of Valvur Regurgitation

Presenter: Linda D. Gillam

March 22, 2019

Presentation ECHO/IMAGING 2019

Doppler Echocardiography Hemodynamic Gold-standards

Presenter: Jae K. Oh

March 22, 2019

Presentation ECHO/IMAGING 2019

Can We Standardize the Definition of Structural Prosthetic Valve Dysfunction?

Presenter: Rebecca T. Hahn

March 22, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Caitlin E. Cox

March 16, 2019

Presentation CHIP at ACC 2019

Weighing Benefits and Risks of Support: A Patient-Oriented Perspective

Presenter: James McCabe

March 15, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Opinion Fellow Talk

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Luai Tabaza, MD

January 10, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

Manuscript

A Paradox between LV Mass Regression and Hemodynamic Improvement after Surgical and Transcatheter Aortic Valve Replacement

May 09, 2017

CME

Advertisement

Interpretation of Hemodynamic, CT, and Echo Data for TAVR Clinical Decision Making

Echo Hemodynamic Cases

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Hemodynamics II Echo Quantification of Valvur Regurgitation

Doppler Echocardiography Hemodynamic Gold-standards

Can We Standardize the Definition of Structural Prosthetic Valve Dysfunction?

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Weighing Benefits and Risks of Support: A Patient-Oriented Perspective

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

A Paradox between LV Mass Regression and Hemodynamic Improvement after Surgical and Transcatheter Aortic Valve Replacement

Low-Risk Patients: The Changing Face of TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content